Respiratory syncytial virus mRNA vaccine(Aibo Biotech)

呼吸道合胞病毒mRNA疫苗（艾博生物）

Report date: 2025/03/04 11:24:37

Base Information

Drug NameRespiratory syncytial virus mRNA vaccine(Aibo Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAbogen Biosciences Co LtdAibo Biotechnology (Shanghai) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAbogen Biosciences Co Ltd
Inactive CompaniesAibo Biotechnology (Shanghai) Co Ltd
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A